Conatus Pharmaceuticals Inc. 4
4 · Conatus Pharmaceuticals Inc. · Filed Oct 31, 2016
Insider Transaction Report
Form 4
Van Wart Harold
Director
Transactions
- Exercise/Conversion
Common Stock
2016-10-27$0.25/sh+18,181$4,545→ 18,181 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-10-27−18,181→ 0 totalExercise: $0.25From: 2007-04-06Exp: 2017-04-05→ Common Stock (18,181 underlying)